The CVPath Institute facility was designed to provide expert translational bench-to-bedside research services utilizing state-of-the-art technology. These services are performed for clients located globally, from Asia to North America to Europe, and for clients of all stages of device development, from emerging technology start ups to Fortune 100 manufacturers.
Histology capabilities include processing and embedding tissues in paraffin, plastic, or OCT compound with histologic sectioning by routine microtomy, crysectioning, and section grinding. In addition, the facility is capable of performing a wide variety of routine and specialized staining techniques. CVPath Institute scientists also manage a full laboratory for cell modeling, molecular biology, protein analysis, immunohistochemistry, morphometry, and high-end instruments for visualization such as laser confocal microscopy, scanning electron microscopy, transmission microscopy, digital radiography, and fluoroscopy.
In addition to being CAP (College of American Pathologists) compliant, the CVPath Institute provides Quality Assurance services adhering to FDA Good Laboratory Practice (GLP) Regulations for Nonclinical Laboratory Studies. This QA service includes overseeing studies from arrival at the CVPath facility to study finalization in order to assure that the study meets FDA regulations.